Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 60

Partial meniscus replacement using Spongioflex®

Official title: Sterile Allogeneic Spongioflex® Allograft As Partial Meniscal Replacement After Incomplete Meniscal Loss, an Investigator-initiated Trial

Run by Maria-Josef-Hospital Greven · NCT06775197 · Data updated 2026-11-12

This study is testing a new type of graft called Spongioflex® to see if it can help younger, active people with meniscus injuries recover better than with traditional methods and avoid future knee problems.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment40 (estimated)
SponsorMaria-Josef-Hospital Greven
Academic / other
Locations1 site (Greven, North Rhine-Westphalia)
StatusRecruiting
StartedNovember 5, 2024
Main results expectedNovember 5, 2029
Study endsNovember 5, 2031
Registry record updatedJanuary 15, 2025
Trial IDNCT06775197 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are males and females aged 18-60 with partial loss of the lateral or medial meniscus and associated joint line pain.

Probably not a fit

Patients over 60 years old, those with significant knee instability, or advanced cartilage damage will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a novel graft, Spongioflex®, for partial meniscal replacement in patients with meniscal injuries. The study aims to determine if this biological material can provide better outcomes compared to traditional replacement methods and prevent the progression to knee arthrosis or the need for knee prosthesis. Patients will undergo the procedure and their postoperative function will be assessed through MRI and clinical knee scores. The trial focuses on younger, active individuals with specific types of meniscal damage.

Why it matters

Potential benefit: If successful, this approach could significantly improve knee function and delay the onset of arthritis in patients with meniscal injuries.

How similar studies have gone: While this approach is novel, previous studies have shown promising results with similar biological grafts in improving knee function.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients (male and female) with:
2. Partial loss of portions of the

   * lateral meniscus and lateral joint line pain OR
   * medial meniscus and medial joint line pain
3. sufficient standing of the peripheral rim, so that the procedure can be performed
4. Age: 18-60 years
5. signed written informed consent to the study and to provide the scientific data in pseudonymized form

Exclusion Criteria:

1. The presence of anterior cruciate ligament insufficiency which is not resolved by reconstruction of the anterior cruciate ligament within 16 weeks after partial meniscal implantation.
2. Axial deviation (\>2° varus or valgus)
3. realignment osteotomy not performed within 12 weeks
4. advanced cartilage damage (grade III according to ICRS) and osteoarthrosis in the affected compartment (grade III according to Kellgren and Lawrence \[33\])
5. Extension deficit of more than 3° compared to the opposite side or a knee flexion of less than 125°
6. inflammatory arthritis or synovitis on the treated knee
7. BMI greater than 30 kg/m²
8. \<18 years, \>60 years
9. Chronic pain patients
10. only for patients who will be operated:

    1. with increased anaesthesiologic risk, e.g., with known or predicted difficult airway
    2. with increased risk of bleeding
    3. with increased risk of infection
    4. with necrotic, infected, or poorly perfused host sides
    5. history of allergic reactions
    6. acute hypersensitivity reactions to the IMP or any of its excipients
    7. pregnant woman

Where it's running

  • Maria-Josef-Hospital Greven GmbH
    Greven, North Rhine-Westphalia, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.